Related Experiment Video
Updated: Dec 10, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
ST Elevations in the Era of COVID-19
Charlie Joseph Sang1, Brittain Heindl2, Gregory Von Mering3
1Internal Medicine-Pediatrics Residency Program, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Insights
Elevated cardiac enzymes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections indicate myocardial injury. Coronavirus disease 2019 (COVID-19) presents challenges for patients with ST-segment changes.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Myocardial injury, indicated by elevated cardiac enzymes, is linked to worse outcomes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections.
- Coronavirus disease 2019 (COVID-19) poses diagnostic and management challenges, particularly for patients presenting with acute ST-segment changes on electrocardiograms.
Observation:
- This report details two unique cases of ST-segment elevation myocardial infarction (STEMI) in patients with active COVID-19 infection.
- The cases highlight the complex interplay between viral infection and cardiovascular events.
Findings:
- The electrocardiogram findings of ST elevation in COVID-19 patients necessitate careful evaluation to differentiate between primary cardiac events and COVID-19-related myocardial injury.
- Prompt diagnosis and tailored management are crucial for improving patient outcomes.
Implications:
- Front-line clinicians must be aware of the potential for ST elevation in COVID-19 patients.
- Understanding these presentations is vital for appropriate diagnostic workups and therapeutic strategies in the context of the COVID-19 pandemic.
Abstract:
Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with COVID-19 and review important diagnostic and management considerations for the front-line clinician.
Related Concept Videos
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Pulmonary Embolism I: Introduction
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Heart Failure III: Clinical Manifestations
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Embolism III: Nursing Management

